ACLY and esophageal squamous cell carcinoma: The results showed that AGK2 could significantly inhibit the proliferation of Eca109 and KYSE150 cells, while ACLY overexpression could partially reverse AGK2‐mediated proliferation inhibition of ESCC cells (Figure 9B–D).